Literature DB >> 11391535

Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis.

S Sakisaka1, T Kawaguchi, E Taniguchi, S Hanada, K Sasatomi, H Koga, M Harada, R Kimura, M Sata, N Sawada, M Mori, S Todo, T Kurohiji.   

Abstract

Tight junctions (TJ) of biliary epithelial cells (BEC) and hepatocytes prevent bile regurgitation from the biliary tract. Alterations in these TJs may participate in chronic cholestatic liver diseases such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC). We examined the localization of 2 TJ proteins, ZO-1 and 7H6, in these diseases. Frozen sections from livers of PBC, PSC, extrahepatic cholestasis (Ex-C), and hepatitis C-associated cirrhosis (LC-C), as well as histologically normal livers, were processed for double-fluorescence immunohistochemistry. In controls and cirrhosis, 7H6 and ZO-1 colocalized surrounding the luminal space of the bile ducts and outlined the bile canalicular spaces between hepatocytes. In untreated PBC, immunostaining for ZO-1 in BEC of bile ducts 40 to 80 microm in diameter was preserved, but that for 7H6 was diminished to absent. In PBC treated with ursodeoxycholic acid (UDCA), immunostaining for 7H6 was well preserved. In PSC as well as in Ex-C, immunostaining for both 7H6 and ZO-1 was well preserved in bile ducts. In hepatocytes, ZO-1 showed preserved immunoreactivity, but immunostaining for 7H6 frequently disappeared. The percentage of bile ducts with immunostaining for 7H6 in all bile ducts with immunostaining for ZO-1 was significantly reduced in PBC compared with that in control, LC-C, Ex-C, and PSC (all P <.0001). Substantial alteration in the TJ protein occurs predominantly in bile ducts in PBC and in hepatocytes in PSC, suggesting increased paracellular permeability along different paracellular routes for bile regurgitation in these chronic cholestatic liver diseases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11391535     DOI: 10.1053/jhep.2001.25086

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

Review 1.  Characterization of animal models for primary sclerosing cholangitis (PSC).

Authors:  Peter Fickert; Marion J Pollheimer; Ulrich Beuers; Carolin Lackner; Gideon Hirschfield; Chantal Housset; Verena Keitel; Christoph Schramm; Hanns-Ulrich Marschall; Tom H Karlsen; Espen Melum; Arthur Kaser; Bertus Eksteen; Mario Strazzabosco; Michael Manns; Michael Trauner
Journal:  J Hepatol       Date:  2014-02-19       Impact factor: 25.083

2.  Hepatocyte γ-catenin compensates for conditionally deleted β-catenin at adherens junctions.

Authors:  Emily Diane Wickline; Prince Kwaku Awuah; Jaideep Behari; Mark Ross; Donna B Stolz; Satdarshan P S Monga
Journal:  J Hepatol       Date:  2011-04-13       Impact factor: 25.083

3.  Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis.

Authors:  Daisuke Asaoka; Hiroto Miwa; Shu Hirai; Akimitsu Ohkawa; Akihiko Kurosawa; Masato Kawabe; Mariko Hojo; Akihito Nagahara; Toshoku Minoo; Ryuichi Ohkura; Toshifumi Ohkusa; Nobuhiro Sato
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

Review 4.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

Review 5.  Blood-Bile Barrier: Morphology, Regulation, and Pathophysiology.

Authors:  Tirthadipa Pradhan-Sundd; Satdarshan Pal Monga
Journal:  Gene Expr       Date:  2019-01-15

6.  Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress.

Authors:  Carlos Felipe Bernardes-Silva; Adérson O M C Damião; Aytan M Sipahi; Francisco R M Laurindo; Kiyoshi Iriya; Fabio P Lopasso; Carlos A Buchpiguel; Maria Laura L Lordello; Carmem L O Agostinho; Antonio A Laudanna
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

7.  Different expression of occludin and ZO-1 in primary and metastatic liver tumors.

Authors:  Erika Orbán; Erzsébet Szabó; Gábor Lotz; Péter Kupcsulik; Csilla Páska; Zsuzsa Schaff; András Kiss
Journal:  Pathol Oncol Res       Date:  2008-04-02       Impact factor: 3.201

8.  γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.

Authors:  Emily Diane Wickline; Yu Du; Donna B Stolz; Michael Kahn; Satdarshan P S Monga
Journal:  Neoplasia       Date:  2013-04       Impact factor: 5.715

9.  Polarisation and functional characterisation of hepatocytes derived from human embryonic and mesenchymal stem cells.

Authors:  Anwar Azad Palakkan; Robert Drummond; Richard Alexander Anderson; Sebastian Greenhough; Kumary Tv; David Colin Hay; James Alexander Ross
Journal:  Biomed Rep       Date:  2015-06-18

10.  SEW2871 attenuates ANIT-induced hepatotoxicity by protecting liver barrier function via sphingosine 1-phosphate receptor-1-mediated AMPK signaling pathway.

Authors:  Zhenzhou Jiang; Luyong Zhang; Tingting Yang; Xue Wang; Yi Zhou; Qiongna Yu; Cai Heng; Hao Yang; Zihang Yuan; Yingying Miao; Yuanyuan Chai; Ziteng Wu; Lixin Sun; Xin Huang; Bing Liu
Journal:  Cell Biol Toxicol       Date:  2021-01-05       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.